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Abstract 
Ultrafine Au quantum clusters (QCs) are synthesized by etching host Au nanoparticles 
in the presence of ethylenediamine (en), exhibiting both high photoluminescence (PL) 
and specific anticancer activity. The cutting-edge of such QC compound involves 
subnanometer size of a rhombohedral Au8, consisting with 8 units of anticancer motif 
Au+(en) complexes (Au(en)QCs), which attribute to photo- and physico-chemical 
stability as well as subcellular theranostic activity in intracellular PL-imaging and 
targeting in situ. Moreover, the Au(en)QCs can be surface-encapsulated by transferrins 
(Tf), creating Tf-Au(en)QCs, as a multipurpose drug carrier due to numerous merits that 
include cancer-selective biolabeling, high loading/release efficiency, high activity against 
drug-resistant tumor cells, low toxicity on normal cells, and physiological stability against 
biothiols, e.g., glutathiones. These versatile features due to the intrinsic optical and 
anticancer property would be potential as a single-drug delivery PL-probe for pre-clinical 
applications, which yet been realized using conventional nanoclusters.   
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 1. Introduction 
Ligand reactivity at metal interface plays critical roles in transition of bulk metals 
undoubtedly into unique nanomaterials with size-dependent properties, and bestows 
them with explicit atomic packing and functionalization. With the advance of ligand-
engineered synthetic techniques, ultrasmall Au nanoclusters (NCs) with a diameter of 
less than 2 nm arranged in confined geometric structures are being emerged as a new 
class of optical probe material that has been extensively investigated in recent years.1-11 
Because these NCs differentiates them from bulk gold, gold nanocrystals, and gold 
complexes, by exhibiting unique quantum size effect in the “molecule-like” discrete 
electronic arrangement of the core together with extremely high surface-to-volume ratio. 
Thus, it is in charge for facilitating the applications in bio-imaging,1-3, 7-12 bio-sensing,1-3, 
9-15 and catalysis,1-3, 12, 16-18  
Normally, few-atom fluorescent AuNCs (Aun, n=2~30) have been prepared by 
“bottom-up” template-based (polymers, DNA, and proteins) or ligand-protected (thiolate- 
or phosphine-capped AuNCs) techniques.1-11 On the other hand, many AuNCs involves 
a “top-down” etching step in which excess thiolated ligands transforms larger 
nanoparticles (NPs) into smaller and more thermodynamically stable ones, exhibiting 
well-defined super-atomic structure with a countable “magic” number of Au atoms and 
discrete transited “molecule-like” electronic or photofluorescence (PL) behavior,1-3, 18-21 
Chen and his collaborators employed DNA, peptides, and amino acids to generate 
atomically precise Au8NCs where they implemented biomolecule-induced etching of 
larger NPs or nanorods.20 Recently, radical initators such as O2 was used for efficient 
etching of gold by thiolates.21 However, the detailed mechanisms of PL-origin have not 
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 yet been clearly elucidated and most of the reported AuNCs have exhibited relatively 
low quantum yields (QY) and low stability over intercellular interferences, i.e., Au-
interaction with serum albumins, enzymes, and biothiols, e.g., glutathione (GSH), which 
preclude their realistic function as PL-biotags.11, 14, 18 Consequently, seminal work has 
presented that the size of these clusters can be quantitatively controlled with atomic 
precision,1-3, 23-25  which this control gives access to tuning the optical and electronic 
properties prospects to realize high PL efficiencies. However, gaining precise structural 
and dynamical information on the ligand poses a major challenge, because the nature 
of the organic/metal interface is often vague visualization of possible distinct ligand 
conformations of the ligated NCs.  
There is an urgent need for new first-in-class anticancer drug candidates to 
maximize effectiveness and selectivity of targeting tumor cells and to minimize side 
effects and drug resistance. The use of dual functions, both imaging and anticancer-
activity, is an ideal way to boost the targeting efficacy of cancer therapy while 
significantly limiting the received dose and the possible damage to normal tissues. In 
this regard, most of reported AuNCs are cytotoxically inert due to the oxidation state is 
Au0, which is only useful for biosafe labeling/imaging application. On the contrary, 
significant advances in valenced Au-based drug agents has been attained by utilizing 
Au+, Au3+, and their coordination ligand complexes as anticancer drugs,26,27 revealing 
favorable cytotoxic specificity in generic cancer and drug-resistance cancer cells for 
some Au complexes over cisplatin,28 though they do not have PL properties. To the best 
of our knowledge, there is no study in the development of organometallic-based AuNCs, 
Page 3 of 35 Nanoscale
N
an
os
ca
le
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
07
 Ju
ne
 2
01
7.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f A
riz
on
a 
on
 0
8/
06
/2
01
7 
09
:2
9:
33
. 
View Article Online
DOI: 10.1039/C7NR02229H
 which shows both fluorescence and tumor-selective activity, to provide multipurpose 
platforms for rational single-drug delivery strategies in a minimally-invasive fashion.  
Here, we demonstrate novel pathway for a simple, rapid, and effective 
preparation of highly fluorescent anticancer-active Au quantum clusters (QCs) at 25 °C, 
through etching host AuNPs by a petite bidentate amino-ligand, ethylenediamine 
(henceforth “en”), followed by a surface stabilization into metal transfer proteins, e.g., 
transferrins (Tf) in the presence of Na2CO3 (Fig. 1). 
 
Fig. 1 (a) Schematic synthesis of Au(en)QCs and its Tf-encapsulation. Bt-AuNPs in 
DCM (i), ethylenediamine (en), 25 °C, 24 h, (ii) Au(en)QCs (showing an Au(en) 
complex-motif), (iii) Tf-encapsulated Au(en)QCs via Na2CO3. (b) Photos of Bt-AuNP (i), 
AuQC (ii), and Tf-Au(en)QC (iii) dispersions, in white light (the top) and UV light (365 
nm) (the bottom).  
 
2. Experimental section  
 
2.1. General procedures  
(b)
iii i ii iii
i ii iii
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N
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 All water used was purified with an EASYpure® RF system (Barnstead, Dubuque, IA; 
18.2 Ω). All solvents and reagents (ACS grade) including dichloromethane (DCM), 
ethylenediamine (en), sodium carbonate, and human serum apo-Tf were obtained from 
Sigma-Aldrich (Saint Louis, MO, USA). The gold salt, HAuCl4, and butanethiol were 
obtained from Strem Chemicals (Newburyport, MA, USA) and Sciencelab.com, Inc. 
(Houston, TX, USA), respectively. The ~2.5 nm butanethiol (Bt)-stabilized gold 
nanocrystals were synthesized according to the modified Brust-Shiffrin method under a 
purified nitrogen atmosphere.29  
 
2.2. Synthesis of ethylenediamine (en)-induced fluorescent AuQCs 
The noble synthesis of Au(en)QCs was carried out via an etching reaction of preformed 
Bt-AuNPs in the presence of en ligands. Briefly, 1 mM of en was added in a test tube, 
containing 2 mg of Bt-AuNPs in 4 mL of dichloromethane (DCM). The reaction mixture 
was incubated at room temperature for 24 h with a gentle stirring. After the reaction, the 
prior brown color of NPs in DCM solution was disappeared, which demonstrated that the 
AuNPs were completely etched. The vapor pressure caused during the reaction was 
carefully ventilated under ambient condition, followed by blowing off the remained 
organic solvent with N2 gas. Then, the sample pellets were re-dispersed in 4 mL of 
ddH2O solution, using by a brief sonication, while the undissolved white-colored 
outbound thiol ligands and excess host AuNPs were separated by a mild centrifugation 
at 5,000 rpm for 30 min. The collected bright green solution was filtered and mixed with 
4 mL of DCM containing 0.1% TFA to discard excess en and adjusted pH to 7.4, 
followed by washing with 4 mL of fresh DCM 10 times, repeatedly. After blowing off the 
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 solvent, the Au(en)QC products was sealed and stored in dark for later studies. Yield 
86%, Elemental analysis was conducted by a Perkin Elmer 2400 analyzer (Waltham, 
MA, USA): Anal. Found % C 9.01, H 1.96 N, 9.65; Calc % C 8.36, H 1.05, N 9.74.  
 
2.3. Encapsulation of Au(en)QCs with human transferrins  
As-prepared Au(en)QCs (0.5 mg/mL) in saline solution (pH 7.4) were added to human 
serum apo-Tf solution (1 mg/mL) in the presence of 15 mM sodium carbonate (pH 7.4) 
and stirred for 3 h in order to sequester the QCs into the Tf proteins. Then, the green-
colored Tf-Au(en)QC complexes were spin down by a centrifugation at 100,000 rpm for 
60 min and collected, following by a washing three times using the centrifugation 
process to remove unbound Tf molecules and Au(en)QCs. The purified products were 
re-dispersed in saline solution (pH 7.4) and briefly sonicated. The products were sealed 
and stored in dark at 4 °C for later studies.   
 
2.4. Quantitation of loading/release of en-AuQCs 
The drug-loading efficiency (DLE) (%) was measured as (Minitial AuQCs – MAuQCs in 
excess)x100/(Minitial AuQCs) (mg/g). The loading/release activity of the Au(en)QC-loaded Tf 
complex was monitored by measuring the PL-emission at λmax 475 nm. Each sample at 
pH 5-8 was centrifuged and its PL-absorbance of supernatant solution was used to 
quantify the amount of Au(en)QCs released toward the supernatant, according to a pre-
determined calibration curve. All of the release profiles are shown in cumulative mode.  
 
2.5. Synthesis of [Au(en)Cl2]Cl2H2O  
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 As a comparative standard anticancer complex, Au(en)Cl2 was prepared according to 
the literature.30 Briefly, HAuCl4 (0.548 mM) and en (0.55 mM) were reacted in absolute 
ethanol at 25 °C for 20 min. Pale yellow crystals of Au(en)Cl2 formed slowly, followed by 
filtration, concentration, and drying steps. Yield 84%, elemental analysis: Anal. Found % 
C 6.11, H 3.01 N, 6.92; Calc % C 6.01, H 3.03, N 7.01.  
 
2.6. Physico-chemical characterizations 
The absorption spectra of AuQC products were obtained using a DU-800 
ultraviolet/visible/near-infrared (UV/Vis/NIR) spectrophotometer (Beckman Coulter Inc., 
Fullerton, CA). The PL emission spectra were collected using a Hitachi F-4500 
fluorescence spectrometer (Hitachi Ltd., Japan) controlled by PL solution software. The 
optical path length of a quartz fluorescence cell was 1.0 cm. The excitation and 
emission slits were all set for a 5.0 nm band-pass. The sample mixtures in square 
quartz cuvettes were excited at 375 nm, and the emission spectra were collected from 
300 to 800 nm. The fluorescence intensity at 475 nm was used to evaluate the 
performances of the QCs. The background for the fluorescence spectrum was deionized 
water for the AuQC, and 0.05 M sulfuric acid for the reference compound 
measurements (neither solution displayed any noticeable fluorescence). The spectrum 
of the reference compound, quinine sulfate (QS), (C20H24N2O2)2H2SO4H2O, dissolved 
in 0.05 M sulfuric acid was recorded immediately after obtaining the QC spectra. The 
absorption spectrum of QS peaks at 349 nm and the excitation wavelength was chosen 
for the QY measurements for the QC solutions. The fluorescence QY was measured 
with an integral sphere (JASCO, ILF-533, ϕ=10 cm) mounted on the fluorescence 
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 spectrometer (JASCO, FP-6600). Sample solution was placed in a quartz sample cell of 
10 mm optical path. The measurement was conducted with a fixed excitation 
wavelength of each sample (QYQS=51%). 
The structural characteristics of the Au(en)QCs were assessed using HRTEM 
and the compositional profiles probed by EDX spectroscopy using a Cs-corrected FEI 
Titan (HRTEM, FEI, Pleasanton, CA, US) operating at 300 kV. For HRTEM analyses, 
1.5 µL of each sample solution was deposited onto a 300 mesh Formvar-coated copper 
grid. No staining was used to alleviate any possibility of artifacts. After dehydration, the 
samples were examined using HRTEM at 300 keV. However, the crystal lattice of Au is 
hardly observed in this TEM image of AuNCs in aqueous solution due to the small size 
(< 1 nm). The NC core dimension is barely identifiable because the image was captured 
immediately after exposure to avoid aggregation of particles due to high energy electron 
beams during the imaging. A multimode AFM (Bruker, CA, US) was used to obtain the 
AFM data in tapping mode. 
To quantify the total amount of gold in the AuQC sample, MS analysis was 
performed. 5 µL of methanol solution of AuQCs was mixed with 95 µL of a matrix 
solution (10 mg sinapinic acid + 250 µL Acetonitrile + 750 µL TFA (0.1% in deionized 
water). Then, 1.5 µL of the mixed solution was dispensed onto the sample plate and 
dried at room temperature. After drying in ambient air, a positive mode mass spectrum 
of the Au(en)QCs were acquired using a MALDI-TOF MS (Shimadzu Corp., Kyoto, 
Japan), operated by a pulsed Nd:YAG laser (355 nm) in the linear configuration.  
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 To quantify the valence state of gold in the AuQC sample, XPS analysis was 
performed by a Kratos Axis UltraDLD 39-306 photoelectron electron spectrometer 
equipped with a monochromated AlKα source operated at 300 W (Manchester, UK).  
To evaluate the surface charge characteristics of AuQCs and Tf-AuQCs, a gel 
electrophoresis was performed. 2% agarose (Gibco BRL, #15510-027) gel was 
prepared by weight in 0.5X TBE buffer (Tris-Borate-EDTA Buffer, #T3913, Sigma-
Aldrich). The solution was heated to around 90 °C and was then cast in a gel tray (Sub-
Cell GT Agarose Gel Electrophoresis System, Biorad, USA). Samples were diluted with 
1/2 volume 1X loading buffer containing 10% glycerol and then loaded into the 
appropriate well (10 µL each) located at center of the gel. Gel was run bi-directionally at 
100 V (8.3 V/cm) for 20 min: The AuQC samples are toward the anode if negatively 
charged or toward the cathode if positively charged. Then, the gel was visualized over 
UV light using a digital camera (Bio-Rad Inc.).  
A Zetasizer Nano ZSP (Malvern Instruments Ltd, Worcestershire, UK) was used 
for dynamic light scattering (DLS) and zeta potential analyses. A PBS solution (pH 7.0, 
100 mM) was used to prepare the Au(en) QC and Tf-Au(en)QC for the measurements 
of their DLS and zeta potentials. 
The fluorescence images of cell samples in the absence/presence of Au(en)QC 
samples were captured by a Zeiss LSM 510 confocal laser scanning microscope system 
through a 100/40 objective lens, and 488 nm lasers were used to excite the QCs at 37 
°C.  
For the pH- and thermo-stability measurements, the pHs of purified AuQC 
products were adjusted from 2 to 10 by adding different amount of 1 M HCl or 1 M KOH. 
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 The PL spectra measurements were triplicated and normalized to evaluate ∆PL%. The 
samples treated at different pH levels were also monitored 6 months after. Investigation 
of the temperature-dependence of AuQCs’ fluorescence was also carried out at the 
range of 25 to 98°C in a conventional thermal cycler in a PCR platform (Bio-Rad Inc.) to 
maintain the thermal uniformity. 
 
2.7. Simulation of Au(en)QC structures 
We performed all electron relativistic calculations with double numerical basis including 
polarization functions,31,32 using the discrete variational method (DVM).31 The 
generalized-gradient approximation (GGA) by Becke, Lee, Yang, and Parr (BLYP)31 
was employed to an exchange-correlation orbital energy function model, which depends 
on both the local electron charge density and the magnitude of its gradient. In order to 
obtain structure of Au8 cluster with the en member rings, we optimized the structure by 
wave functions and eigenvalues. Firstly, we set molecular structure according to a 
chemical formula of Au8 cluster with the en member rings. Secondly, we dynamically 
optimized the structures without any empirical parameters. The structural optimization 
method is the direct inversion in the iterative subspace.31 By resolving Kohn Sham 
equation that can approximate Schrödinger equation, in which the energy of a molecular 
or bulk state can be expressed as a function of electron charge density,31 we were able 
to obtain the physical and chemical properties through wave functions and eigenvalues. 
 
2.8. Cell culture, cell viability assay, and cell labelling/imaging 
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 The human ovarian carcinoma A2780 and A2780cis cell lines were attained from 
Sigma-Aldrich. Human ovarian epithelial cell line (SV40) was obtained from Applied 
Biological Materials (ABM) Inc (Richmond, BC, Canada). Human melanoma cancer and 
HeLa cell lines were purchased from American Type Culture Collection (ATCC, 
Manassas, VA). These cell lines (~104 cells) were seeded in RPMI-1640 with L-
glutamine and phenol red medium containing 10% fetal bovine serum and 1% 
penicillin–streptomycin. The culture media was replaced with fresh media and cultured 
for a further 48 h. After dispensing 100 
µL of cell suspension (~5x103 cells per well) in a 96-well plate, the plate was pre-
incubated for 24 h in a 5% CO2 incubator. The cell density was kept constant at ~4x10
4 
cells per well in the whole study unless otherwise stated. Then, the cell wells were 
exposed to different concentrations of the AuQCs, Tf-AuQCs, Au(en)Cl2, or cisplatin 
(0.2-50 µM) for 24 h at 37 °C. After treatment, each well was incubated with 0.5 mg/mL 
XTT reagent for 4 h at 37 °C. Consequently, the absorbance at 450 nm was measured 
with a Multiskan GO UV-Visible spectrophotometer. The viability of treated cell wells 
was obtained as a percentage of the viability of unexposed wells. For live cell 
labeling/imaging, the cells were seeded at an initial density of ~4x104 cells per well in a 
12-well culture plate. After 24 h incubation, the cells were exposed to 20 µM AuQCs or 
Tf-AuQCs in culture media for 2 h at 37 °C in a 5% CO2 incubator, and then washed 
twice with PBS (pH 7.0, 100 mM) before imaging. Live and dead cell viability assay was 
used for separately staining the samples. Briefly, propidiumiodide (PI) solution (2 µL, 1 
mg/mL in DMSO) was added to each well followed by 15 min of incubation for staining 
dead cells, while the live cells without the QC samples were stained with the same 
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 amount of calcein AM solution. Finally, each well was washed with PBS twice and then 
transferred for PL imaging. 
 
3. Results and discussions 
3.1. Synthesis and characterization of Au(en)QCs and Tf-Au(en)QCs. 
We employed a simple phase transfer system to create water-soluble AuQCs from Bt-
AuNPs in organic solvent. The phase transfer was induced in the presence of en, as 
both ligand replacement and stabilizing reagent, resulting in a water-immiscible QC with 
an Au-en coordination mimics an anticancer Au complex (Au(en)Cl2). The QCs were 
encapsulated into the Tf, in the presence of Na2CO3, showing similar characteristics of 
fluorescence as presented in Au(en)QCs. Panels in Fig. 1b show the sample photos, 
exhibiting significant photoactivity upon a UV light.  
 
Compared with a surface plasmon resonance (SPR) curve of Bt-AuNPs at 520 
nm in the UV-vis absorbance spectrum, the AuQCs exhibited a dramatically blue-shifted 
absorption onset at 310 nm with a shoulder around 250 nm (Fig. 2a). Thus, it proposes 
that the host AuNPs found to be fragmented to a very small NCs as a characteristic of 
quantum-sized NC formation via NP-etching process.19 The purification steps were 
effective for improving the uniformity of the QCs by discarding larger sized non-
fluorescent NPs as byproducts. Rather than a flat characteristic shoulder peak of 
quantum sized NCs, the unique absorbance peak at 310 nm is noteworthy because it 
proposes that heterocyclic en ligands were formed on the AuNCs, whereas free en 
ligands do not possess aromatic rings that absorb in this band. Notably, absorption 
features of AuQCs are different from that of AuQCs embedded in apo-Tf proteins, 
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 observing the onset of the curve was faded by which this absorption variation highlights 
successful incorporation of the QCs inside the metal binding pockets of apo-Tf proteins. 
The AuQCs and Tf-AuQCs maintain their high steady-state PL and narrow blue 
emission at 473 nm (Fig. 2b). The PL spectra of both AuQCs and Tf-AuQCs showed 
same intensity of excitation and emission curves at 318 nm and 473 nm, respectively 
(Fig. S1). The large Stokes shift in the emission where the absorption band shoulder 
appears at around 318 nm and the PL-emission maximum is shown at 473 nm, is 
correlated with the excited state, which is likely to have a significant geometric 
alteration. Apparently, their interfacing through a ligand replacement between thiol-
ligands (Bt) on AuNPs and incoming excess amino-ligands (en) due to the affinity 
difference of these ligands on Au would result in a non-equilibrium coexistence system, 
which is responsible for releasing Au ions from AuNPs. Hence a conversion into a 
continuous size-trim downed UV responsive cluster dimension would be occurred so as 
to form an equilibrium state that may be consisted of a few atomic Au cores and 
monolayer of en-ligand-coordinating Au atoms, as similarly discussed in the report using 
poly-ethyleneimine (PEI).19 This transition can be often observed where SPR from 
AuNPs diminishes and PL arises at the AuQC size regime, which is known that the PL 
property is attributed to molecule-like transitions due to their finite cluster size.1-6 
According to the spherical Jellium model,6 smaller AuQCs emit stronger PL at shorter 
wavelengths. As a result of PL spectra versus a quinine standard (QY=53%), the 
photophysical property of AuQC and Tf-AuQC samples showed relatively high QYs of 
26 ± 0.3 % and 24 ± 0.6 %, respectively, which is superior to that of previously studied 
etching-based AuQCs (QY=4~20%),1-3, 18-21 as well as Au complex-based PL-
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 compounds (QY=10~15%).33-36 Furthermore, both QC samples showed very good PL-
stability, allowing to vaporize the water under vacuum and to re-disperse them again 
preserving intact their PL properties, while traditional organic dyes usually demonstrate 
fast photobleaching, and thus, enabling us to use for bio-labeling/imaging. High QY level 
of AuNCs is mainly associated with well-defined Au core size with its intrinsic 
quantization effects and the surface properties of which are directed by the chemical 
interfaces between the Au core and the surface ligands.25 Usually, the synthetic method 
(either a reduction- or etching-based approach) involves the formation of non-
fluorescent NPs as byproducts as well as inhomogeneous Au cores, which can lower 
the synthetic yield, purity, and PL QY level.7 For example, Liu et al reported that 
dimethylformamide (DMF)-protected AuNCs,37 which involved a mixture of various-sized 
AuNCs of less than 20 atoms including at least Au8 and Au13; the ssDNA-protected 
AuNCs18 contain Au7 (~0.9 nm) of Au
+ and Au0 cores; PEI-etched Au8NCs also contain 
larger AuNPs.19  In this report, the increased QY level would be primarily attributed to 
the defined small Au8 core size by excluding larger counterparts and other valenced Au 
cores, via the several purification steps that were efficient for improving the 
monodispersity and QY of the QCs. In addition, the unique surface such as heterocyclic 
en ligand-Au interface would also play a major role in the high QY of the QCs. 
 
Recently, to gain fundamental insights into the origin of PL in AuQCs, Martinez et 
al recently synthesized ssDNA-templated luminescent Au7QCs that the PL of QCs are 
attributed to the cationic Au+ states, rather than Au0 form in the presence of sulfur.18 
Whereas bigger sized AuNCs (>1 nm) with rigid ligands are mostly Au0 state and their 
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 PL properties are supposed to be independent to an additional reduction, the valenced 
states of subnanometer QCs against sulfurs are supposed to play a significant 
functional role in PL, as well as redox property.18 Likewise, in our study, since the PL of 
AuQCs were lessened as GSH concentration increased (Fig. S2a), we attempted to 
protect the QCs by embedding into a surface-protective carrier, e.g., Tf, for the purpose 
of targeting cancer cells and avoiding undesirable cytotoxicity against normal cells. The 
loading efficiency was ~43.8% in the presence of sodium carbonate (20 mM) (Fig. S2b), 
in good agreement with the report that metal ion couples to apo-Tf only in the presence 
of carbonate that serves as a linker between cationic metals and proteins.38 
Remarkably, no significant effects in the loss of PL intensities were observed for the Tf-
encapsulation of QCs (Fig. 2b), implying that the Tf-Au binding did not influence the PL 
property due to the weak interaction between Tf and Au, rather than covalent binding 
that triggers Au reduction or aggregation resulting in loss of PL.  
 
Based on the high-resolution TEM result, the size of monodispersed Bt-AuNPs 
was ~2.5 nm (Fig. 2c), whilst the DLS analysis confirmed uniform distribution with 
hydrodynamic diameter of 3.08 ± 1.1 nm (Fig. S3). On the other hand, the mean 
diameter of AuQCs (>90 % conversion of Au atoms on NPs) was determined to be 0.87 
± 0.27 nm by the TEM size distribution analysis (Fig. 2d, Fig. S4). Typically, the atomic 
clusters smaller than 1 nm are too small to be visible under TEM observations. For 
example, the DMF-protected Au11 clusters are not visible under TEM.
37 As a rare case, 
the size of ssDNA-protected Au7 clusters were barley determined to be ~0.9 nm,
18 
which can support our TEM result. The Bt-AuNPs’ substantial size reduction and 
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 compositional changes were also proven by the energy-dispersive X-ray (EDX) spectra 
(Fig. S5). Thus, contrasting the hyperbranched-ligand (PEI) stabilized AuQCs,19 these 
methodologies are the first successful top-down etching methods on AuNPs using the 
smallest ligands (e.g., 
 
  
Fig. 2 Optical and morphological characterizations. (a) UV-vis-absorbance and (b) PL 
spectra of Au(en)QCs and Tf-Au(en)QCs. (c) TEM of Bt-AuNPs, (d) HRTEM of 
Au(en)QCs.   
 
en), which could produce more diminutive QCs than the conventional QCs in the final 
size with ligands. 
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 The exact number of atoms present in the core of these NCs have been 
determined by a positive mode MALDI-TOF MS analysis (Fig. 3a). The monodispersed 
maximum mass was observed at ~2038.1 m/z with the interspacing of 1 m/z (Fig. 3a, 
inset), which reveals the AuQC was formulated as an 8-atom Au ligated by 8 en 
molecules (Au:N=1:2)  with the oxidation state of +1. Based on the X-ray photoelectron 
spectra (XPS) (Fig. 3b). The principal Au core level spectrum of the QCs shows an 
intense and sharp peak at ∼84.7 eV and a less intense peak at ∼88.25 eV, 
corresponding to the Au 4f7/2 and Au 4f5/2, respectively, which reveals that the AuQC 
has characteristics of clusters with Au+ oxidation states, correlating to the MS result. 
The N 1s XPS spectrum (Fig. 3b, inset) also confirms that typical peak of NH2 species 
from the en ligands at 401.3 eV was shifted to 398.7 eV, offering an insight into that N 
atoms of en are adsorbed on Au in the AuQC rather than remaining as NH2. From these 
spectra, the relative atomic % of Au and N are found to be 0.82% and 1.6%, 
correspondingly, yielding Au-N with 1:2 ratio, which is also approved with the MS result. 
Therefore, the QCs are referred as [Au8(en)8]
+, mimicking a structural coordination of 
Au+(en)Cl2, which confirms our initial rationale that the en-ligand is critical in forming the 
anticancer-active charged Au moiety and protecting the QCs.  
 
3.2. Simulation of Au(en)QCs  
With the help of MALDI-TOF-MS and XPS results on AuQC structure, to predict the 
precise structure of AuQCs, we have conducted First principle calculations, revealing 
that a theoretical structure of QC is a cube with symmetry of P1. Markedly, in the 
presence of en ligands on the NCs, the structure at the lowest energy evolved to form a 
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 rhombohedral cube with a chiral symmetry of C1 (Fig. 3c, i and Movie S1). The shape 
of QC isomer is equivalent with the excited state with large Stokes shift due to its 
distorted cubic structure, which is clearly distinctive comparing previously reported 
models of Au8 isomers that typically exhibit a group of nonplanar nugget shape (Td, C2v, 
D2d) at the lowest energy.
39 Comparing with the structure of Aun (n>8) QCs that have 
been relatively resolved, the studies on revealing Aun (n<9) QC structure have been 
challenged because the prediction of ligand effects on the Au structure formation is 
difficult.39  Based on our geometric and electronic structure calculations of bonding 
energies of the en-ligated AuQCs, it holds potentially high chemical stability in the 
bonds between their Au8 kernels and the en rings, where the two N-groups of en rings 
were tightly attached on each gold atom, enabling rigid covalent binding of Au-N. 
Accordingly, the QCs showed isosurfaces of electrophilic (Fig. 3c, ii) and nucleophilic 
(Fig. 3c, iii), denoting that the AuQCs can be chemo-sensitive against reactive counter 
molecules, whilst no radical entity was found in the QCs. The HOMO-LUMO gap of the 
cluster was found to be 0.1456 eV, greatly lower than that of the Au8 nuggets (1.2874-
1.8882 eV),39 presuming that our QCs are chemically reactive most likely due to the 
amphoteric (redox) charge characteristic of Au+-en-coordination, rather than a neutral 
Au structure, in consisted with the CV, gel electrophoresis, and the biological activity 
results as descried in the next section. In other words, the small E gap might be 
attributed to the covalent link between the electron donor of en ligand (high HOMO) and 
electron acceptor of Au+ (low LUMO) in the Au-N coordination, as discussed in the 
literature.40 Besides, the powder X-ray diffraction (XRD) pattern of AuQCs (Fig. S6) 
showed that a single crystal feature with air scattering, which is analogous to the 
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 previous results on aggregated Au complex-based fluorescence AuNCs,33-36 unlike that 
of common AuNCs. Thus, this result supports that our product possesses a structural 
novelty over  
 
Fig. 3 Structural characterizations of Au(en)QCs. (a) MALDI-TOF mass spectrum (inset: 
an isotopic spectrum) of Au(en)QC. (b) Au 4f core level photoelectron spectrum of the 
Au(en)QCs (inset: N 1s core level photoelectron spectrum of the QCs). (c) The 
simulated Au(en)QC structures. The 3-D structure of Au8 cluster with en rings (i) and its 
electrophilic (ii), nucleophilic (iii), HOMO (iv), and LUMO (v) states. 
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 traditional AuNCs. In view of our early hypothesis that our QCs imitate a clustered 
Au+(en) complex, the Au(en) moiety at the confined size-transition aggregates into a 
QC, becoming emissive due to intermolecular aurophilic interactions,33-36 which can be 
allocated to the weak intermolecular AuAu interaction between the closest pair of Au 
atoms,33 aside from the shortened AuAu contacts via the thermodynamic 
stabilization.36 
 
3.3. Fluorescence imaging and therapeutic activity of Au(en)QCs 
 To evaluate in vitro efficacy of the AuQCs in cellular uptake and labeling, we performed 
a confocal fluorescence imaging. The QCs were transported into cells and located in the 
cytoplasm, fluorescing blue color (Fig. 4a). The bright PL intensity indicates that 
outstanding cellular uptake due to their small size. However, the cell morphology was 
found to be changed over time, representing that they were dead after 24 h incubation 
with the QCs (Fig. 4b), which also confirmed by a dead cell imaging in Fig. S7a. In the 
presence of possible physiological interference, BSA, the medium sample containing 20 
mM BSA with the QCs at pH 7.0 showed substantial toxicity, except at pH 12 where the 
reduction ability of BSA activated the thiol-Au bonding on the QCs, resulted in inert. 
Likewise, the QC sample containing 20 mM GSH showed substantially decreased cell 
death as a consequence of the high thiol reactivity of Au+ in the QCs, resulted in low 
cytotoxicity (Fig. S7b), reflecting that such a standalone AuQC structure is reactive to 
thiols, in accordance with the results of PL of AuQCs under GSH (Fig. S2a) and the 
simulation-based chemical reactivity (Fig. 3c, ii, iii).  
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 Fig. 4 Confocal microscopic images of ovarian cancer cells (A2780) after incubation 
with Au(en)QCs (20 µM) for (a) 2 h and (b) 24 h. (i) Merged bright field (BF) and DAPI, 
(ii) magnified BF, and (iii) DAPI modes, demonstrating morphological change of cells. 
Scale bar: 40 µm. 
 
 
Fig. 4 Confocal microscopic images of ovarian cancer cells (A2780) after incubation 
with Au(en)QCs (20 µM) for (a) 2 h and (b) 24 h. (i) Merged bright field (BF) and DAPI, 
(ii) magnified BF, and (iii) DAPI modes, demonstrating morphological change of cells. 
Scale bar: 40 µm. 
 
3.4. Structural and physico-chemical characterizations of Tf-Au(en)QCs. 
The TEM and AFM results exhibited the size of a Tf-encapsulated AuQC is ~5 nm and 
~5.6 nm, correspondingly (Fig. 5a,b), while the hydrodynamic size via a DLS analysis 
was ~20.3 nm (Fig. S8a). The MALDI-TOF analysis showed a distinct peak at 81025 
and a slight peak at 329985 m/z (Fig. 5c), pointing out dissociated Tf proteins and a 
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 trace of some non-dissociated Tf-AuQC complexes, correspondingly. The first curve at 
~81k m/z is identical with that of free apo-Tf (~81k Da) (Fig 5c, inset), which indicates 
that the AuQCs and Tf were dissociated because they are not covalently bound in good 
agreement with the PL stability. On the other hand, the AuQCs and functional groups of 
Tf proteins (e.g., thiols of cysteine) can be non-specifically adsorbed by the UV laser 
light (337 nm) of MALDI, and some of the adsorbed ones were appeared in the second 
peak at ~330k m/z in the MS spectrum: the use of the MS soft ionization process allows 
us to postulate the mass of Tf-AuQCs can be detectable in the MALDI-MS as an 
alternative means of tracking weakly bound metal-protein complex samples. All these 
data implied that ~10 QCs (core) may be loaded into 4~5 Tf molecules (~5 nm shell), 
leading to a ~20 nm core-shell drug delivery formulation as simulated in Fig. 1a. 
Besides, to verify electrochemical feature of the Tf-AuQCs over the free AuQCs, cyclic 
voltammetry (CV) was performed. The CV data of the AuQCs (Fig. 5d) showed two 
closely adherent peak currents at 0.083 and 0.188 V in related to a sequential one-
electron oxidation/reduction (double Au+/Au0 processes) of the QCs,18 whereas 
observed disappearance of the peak currents in Tf-AuQC sample is characteristic of the 
formation of core-shell nanostructure. In addition, the 2% agarose gel electrophoretic 
migration pattern of the QC products determined not only their surface charge 
characteristics, but also outstanding photostability over the continuous electric field, 
along with high monodispersity and purity in water (Fig. 5e). Likewise, the zeta potential 
analyses of the AuQCs and Tf-AuQCs showed +26.5 mV and -27.3 mV, respectively, 
confirming the outstanding colloidal stability and charge property (Fig. S8b). 
Furthermore, the AuQCs exhibited high photostability at all pHs (4~8) without showing 
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 any substantial aggregation or reduced PL under ambient condition for at least 6 
months, except a prolonged exposure at pH 2-3 and pH 9-10 led to slight decrease in 
the PL intensity (Fig. S9a). The extraordinary stability was probably due to the tightly 
ligated bifunctional amine ligands of the en on each Au atom of AuQCs. During the 
etching  
 
 
Fig. 5 Structural analysis of Tf-Au(en)QCs using (a) TEM, (b) AFM, and (c) MALDI-TOF 
MS (inset: a control MS of free Tf). Surface characteristics of Tf-Au(en)QCs by (d) cyclic 
voltammetry in contrast to Au(en)QCs and (e) the gel electrophoretic analysis (the 
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 arrow: an electric field (E) applied to a gel matrix), verifying charge property and 
chemical purity. 
 
process, these shell molecules are presumably packed on the surfaces of the AuNCs 
and shield them from direct contact with the solution. Comparing with Au(en)Cl2 
complexes that are known to undergo hydrolysis in water at pH >2.5~3.0,30 the AuQCs 
are more thermally stable than Au(en)Cl2 due to the replacement of 2 Cl ligands by 
adjacent gold atoms, allowing the QCs highly tolerant to oxidation over the broader pH 
range; the compact Tf-shells thoroughly encapsulate the core AuNCs, enabling 
appropriate optical stability at pH 7-8, except showing reduced PL which may be due to 
the dissociation/decomposition between the QCs and Tf proteins. These results allow 
us to propose that the AuQCs can be a promising potential as a powerful biotag-based 
assay tool. Based on the pH-dependent release study of the AuQCs, the QCs were 
released upto ~44.5% at pH 5.5 (Fig. S9b), which implies the release profile is 
associated with a pH-dependent metal-Tf binding kinetics, although the dissociation 
constant (Kd) of monovalent Tf would be lower than those of other complexes, e.g., 
Au3+-Tf, Fe3+-Tf, or Fe+-Tf.38,41  Furthermore, we performed that an electrophoretic 
analysis of the Tf-Au(en)QC samples at different biological pH, which also presented 
the dissociation of Au(en)QCs from the Tf-Au(en)QC complexes at pH 5.5 (Fig. S10). 
Hence, in a lysosomal condition at pH 5.5, the QCs were released in response to the 
pH, which supports the reversible interaction of the QCs inside Tf in the presence of the 
carbonate anions. 
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 We also systematically investigated other effects such as salt concentrations of 
the solutions (0-0.5 M) and photo-irradiation (0-48 h) on the colloidal stability of the 
QCs. By kinetically monitoring the QY values with the PL-spectroscopy (Fig. S11), we 
found that the QCs are stable for quite a long time against an UV-irradiation (at least up 
to 18 h) in the presence of salt (up to 0.25 M), which was not induced evident quenching 
within possible intense environments, except an extreme condition at 0.25-0.5 M salts 
for 18-48 h exposure. 
 
3.5. Anticancer imaging and targeting activity of Tf-Au(en)QCs. 
Consequently, we employed the Tf-AuQC formulation as a nanocarrier design in order 
to evade the extracellular interferences and to improve targeting efficiency in a selective 
manner (because the AuQCs have relatively low selectivity between cancer cells and 
normal cells). Tf-encapsulation of the AuQCs to form Tf-AuQCs significantly improved 
both labeling efficiency and cytotoxicity to cancer cells (Fig. 6a), while showing minor 
cytotoxicity to normal ovarian cells (Fig. 6b). As presented in Fig. 6c, most of cancer 
cells were brightly labeled after 24 h incubation with the Tf-AuQCs (20 µM), and 
considerably dead (~66%), while only ~4% of the normal cells were nearly unlabeled 
and vaguely dead. This implies that the presence of surface Tf proteins on the AuQCs 
could inhibit a thiolate adsorption and prolong the drug circulation time in vitro. Release 
of the cargo into cytoplasm might be occurred due to the dissociation of the QCs from Tf 
shells in ribozyme pH (pH<7), leading to targeting and fluorescence staining, 
simultaneously. The mechanistic anticancer effect behind the release machinery can be 
presumed as illustrated in Fig. 6d: (i) When Tf-proteins are binding to their receptors on 
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 the cell surface, (ii) the Tf-receptor complexes are promptly internalized and forms 
endosomes, where the complex is subjected to a drop in endosomal pH (pH 5.5-6.0), 
which weakens the linkage between Au+ and Tf: metal release from Tf normally involves 
protonation of the carbonate anion, relaxing the metal-protein bond.38,41 The escaped 
QCs are ultrasmall enough to be penetrated in organelles, e.g., lysosomes, 
mitochondria, and nuclei, leading to antitumor targeting by cell necrosis or apoptosis. An 
excess amount of free-Tf sample against the tumor cells did not show any substantial 
toxicity, verifying the Tf-receptor-mediated tumor targeting efficacy of Tf-AuQCs (Fig. 
S12). As a result, as-synthesized QCs can be thought of as a “silent marker” of where 
the luminous anticancer marker is cloaked by metal transfer proteins against serum 
interferences, and executed the target only.  
However, little is identified regarding the detail mechanistic cytotoxicity of AuNCs 
after they enter the cell organelles. In this study, we have found that the Au(en)QCs 
have high reactivity of their gold-ligand interface with large surface area-to-volume ratio 
that might be responsible for the generation of reactive oxygen species (ROS). Based 
on the bright color throughout the entire cell, it is certain that their ultrasmall size 
expedites their internalization into most of the cytoplasmic organelles, i.e., lysosomes, 
mitochondria, as well as cell nucleus through nuclear pores. Although the cell uptake 
efficiency is high, it is difficult to selectively localize the QCs in a specific organelle as 
described elsewhere.42 Because most of the cell constituents including nucleus and 
mitochondria stained by the QCs, a possible mechanism for the cytotoxicity in the 
subcellular targeting can be proposed as follows: the QCs locate into nucleus and 
mitochondria induce ROS), causing cellular apoptosis via a mitochondrial damage 
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 pathway. Therefore, further work is required to direct a better understanding of the 
toxicity mechanism of the QCs by examining the cellular parameters, such as cell 
signaling process, ROS level, and mitochondrial membrane potential, in addition to a 
site-specific trafficking and targeting of an organelle for advanced applications.  
Most clinical anticancer agents are ineffective against drug-resistant cancers 
such as melanoma, non-small cell lung cancer, and glioblastoma,43-45 since the drugs 
act through the induction of apoptotic cell death.46,47 Recently, several metallodrugs 
have been explored as potential apoptosis-independent anticancer drug candidates.48-51 
In our study, contrasting conventional anticancer metal complexes, e.g., cisplatin and 
Au(en)Cl2,  
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 Fig. 6 Cancer cell imaging and targeting by Tf-Au(en)QCs. Microscopic images of (a) 
ovarian carcinoma (A2780) and (b) epithelial normal cells (SV40) stained with the 20 µM 
QCs, showing bright field (i), QC-labeled (ii), and dead (iii) cells. Scale: 200 µm. The 
corresponding cell viability by the XTT assay (c). Mechanism of Tf-receptor-mediated 
intracellular labeling of QCs and cancer treatment (d) by cell uptake via Tf-receptors (i), 
endocytosis (ii), and release into cytoplasm, where DNA in nuclei or mitochondria can 
be targeted, resulting in apoptosis/necrosis (iii). The dose-dependent cell proliferation 
profiles of the QCs over cisplatin-sensitive cells (A2780) (e) and cisplatin-resistant cells 
(A2780 cis) (f). 
 
as-prepared Tf-AuQCs displayed the intrinsic cytotoxicity (EC50=~6 µM) that was 
substantially lower than that of cisplatin (EC50=~1.5 µM) against A2780 (cisplatin-
sensitive) cells (Fig. 6e). Furthermore, they appeared to be much better cytotoxic in 
A2780 cis (cisplatin-resistant) cells (EC50=~2 µM) over A2780 (Fig. 6f), supporting our 
hypothesis described earlier about the different antitumor mechanism of action in 
contrast to that of cisplatin in which DNA is the only target: we can conclude that their 
cytotoxicity might be primarily derived from an alteration of mitochondrial function and 
inhibition of protein synthesis, along with the possible DNA damage. Therefore, this 
result would allow us to utilize as-prepared QC products for potential cancer targeting 
not only in sensitive and selective treatments, but in minimizing drug resistance and 
possible side effects.  
Additionally, the QCs and Tf-AuQCs presented similar bioactivity against other 
cancer cell lines including HeLa and human melanoma cells (Fig. S13), which 
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 envisages clinical efficacy for maximizing anticancer effects toward various tumors, as 
well as potentiating treatment for apoptosis-resistant cancers, e.g., melanoma. Although 
adding same quantity of AuQCs and Tf-AuQCs into the cell lines, the Tf-free distribution 
of AuQCs was appeared to be slightly more cytotoxic than the receptor-based pathway 
of Tf-AuQCs (Fig. S13), which might be due to a limited capacity of the Tf-receptors, 
where only 20% of them are on the cell surface in cancer cells,52 e.g., HeLa cells, while 
the smaller sized AuQCs could be directly internalized through the cell membrane pores 
by passing the ligand-receptor recognition.  
However, the ultrasmall size of AuNCs exhibited cytotoxicity as an immense 
concern based on several studies have informed their adverse effects.51,53,54 In 
particular, the occurrence of drug/apoptosis resistance leads to the failure of tumor 
treatment, involving serious side effects, which is a challenging obstacle to overcome. A 
low selective anticancer drug with high drug resistance would require a higher 
concentration and continuous dose, inherently cause the side effects. Thus, the results 
in this report showed anticancer activity of as-prepared QC products for potential cancer 
targeting in sensitive and selective treatments, which minimized drug resistance or 
apoptosis-resistance with a single treatment in a low dose level. Accordingly, we believe 
that as-prepared QCs at least could minimize the overdose-provoked potential side 
effects. Nonetheless, we are unable to specify the detail side effects in this scope of 
investigation, because we have no in vivo results, e.g., inflammation, infection, or organ 
damage, to verify resolved biological response. 
 
4. Conclusions 
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 Novel Au(en)QCs were readily prepared by etching host AuNPs via a small-ligand (en)-
exchange-assisted atomic clustering technique. The physico-chemical studies of the 
QCs disclosed that its atomically precise unique structure is a subnanometer-sized 
rhombohedral cubic Au cluster, which composed with eight of Au atoms and en ligands, 
holding eight anticancer motifs of Au+(en) complex in a single super-atomic system. 
Extraordinarily, they exhibited highly bright and stable blue PL with high QY, good 
water-solubility, electrochemical redox-activity, and anticancer activity. Moreover, the 
anticancer QC-delivery vehicles were formulated by encapsulating the QCs in apo-Tf 
proteins via weak Au-Tf affinity, presenting enhanced cancer targeting efficacy in high 
capacity loading, cancer-selective imaging, controlled release, and cancer-specific 
targeting (especially effective for drug-resistant tumors). These novel QC-protein 
hybrids would be appropriate multipurpose biotags for intracellular imaging/targeting as 
an alternative metal complex-based chemotherapeutic drug, due to their ultrafine size, 
robust photostability, and selective anticancer activity. Even if the Tf-Au(en)QCs 
showed early signs of multifunctional minimally-invasive biocompatible drug delivery 
carrier, it is expected that many more in vivo and in vitro trials will be piloted toward 
generic theranostic clinics beyond the current research stage. Yet, further mechanistic 
optical investigation of the missing link between the super-atomic scale (Au8 core) and 
molecular scale that is associated with the PL property of ligand-Au clusters, together 
with further biological effects of the Au(en)QCs, remains to be explored.  
 
Electronic supplementary information (ESI) Available: The ESI is available free of 
charge on the RSC Publications website at DOI: 
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 A movie file of Au(en)QC simulation (Movie S1); The additional figures as described in 
the text (Fig S1-S13).  
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